Alzheimer's disease & dementia

Here's what we think Alzheimer's does to the brain

Around 50m people worldwide are thought to have Alzheimer's disease. And with rapidly ageing populations in many countries, the number of sufferers is steadily rising.

Alzheimer's disease & dementia

Unraveling Alzheimer's: New study documents how brain cells go bad

In the brains of people with Alzheimer's disease, there are abnormal deposits of amyloid beta protein and tau protein, and swarms of activated immune cells. But scientists do not fully understand how these three major factors ...

Alzheimer's disease & dementia

Structural analysis of relevant drug targets for Alzheimer's disease

Alzheimer's Disease (AD) is classified as a neurodegenerative non-curable disease that affects millions worldwide. Current drugs have side effects that are significant. In AD, the beta-amyloid precursor protein (β-APP) that ...

Alzheimer's disease & dementia

Focus on Alzheimer's disease shifts to prevention

It has been 111 years since Auguste D. became the first person described with what is now called Alzheimer's disease. German psychiatrist Alois Alzheimer, for whom the disease is named, first publically reported his observations ...

Alzheimer's disease & dementia

Never before seen images of early stage Alzheimer's disease

Researchers at Lund University in Sweden have used the MAX IV synchrotron in Lund – the strongest of its kind in the world - to produce images that predate the formation of toxic clumps of beta-amyloid, the protein believed ...

Alzheimer's disease & dementia

Gut bacteria may play a role in Alzheimer's disease

New research from Lund University in Sweden has shown that intestinal bacteria can accelerate the development of Alzheimer's disease. According to the researchers behind the study, the results open up the door to new opportunities ...

page 29 from 38